Introduction
Alzheimer's disease (AD) is the most common form of dementia occurring in the aged population. The pathology of AD is characterized by the deposition of ␤-amyloid plaques, of which the principal components are 40 and 42 amino acid ␤-amyloid peptides derived from the amyloid precursor protein (APP). Although ␤-amyloid plaques are the hallmark of AD, loss of synapses is closely associated with the duration and severity of cognitive impairment in AD patients (Terry et al., 1991; Masliah and Terry, 1993) . These observations lead to the notion that synaptic dysfunction is a critical element of the pathogenesis of AD (Selkoe, 2002) . Because of the pivotal role of APP in AD pathogenesis, it is essential to understand its physiological function, particularly its potential activity in synaptic regulation.
APP belongs to a family of conserved type I transmembrane proteins including Apl-1 in Caenorhabditis elegans (Daigle and Li, 1993) , Appl in Drosophila (Rosen et al., 1989) , and APP (Tanzi et al., 1987) , APP-like protein 1 (APLP1) (Wasco et al., 1992) , and APLP2 (Wasco et al., 1993; Slunt et al., 1994) in mammals. Within the nervous system, APP can be detected on the membranes of synaptic preparations (Kirazov et al., 2001 ) and has been shown to localize to the postsynaptic densities, axons, and dendrites (Schubert et al., 1991; Shigematsu et al., 1992) . APP undergoes rapid anterograde transport (Koo et al., 1990; Sisodia et al., 1993; Yamazaki et al., 1995) and is targeted to synaptic sites of both central and peripheral nervous systems, including neuromuscular junctions (NMJs) (Schubert et al., 1991; Shigematsu et al., 1992; Akaaboune et al., 2000) .
To understand the in vivo function of APP and its family members, individual APP, APLP1, and APLP2 null mutant mice have been generated (Zheng et al., 1995; von Koch et al., 1997; Heber et al., 2000) . These single null animals are viable and fertile, although aged mice deficient in APP show impairment in behavior and long-term potentiation (Zheng et al., 1995; Dawson et al., 1999; Phinney, 1999; Seabrook et al., 1999) . The subtle phenotypes observed in each of the single null animals could be attributed in part to genetic redundancies, because mice doubly deficient in APP and APLP2 or APLP1 and APLP2 exhibit early postnatal lethality (von Koch et al., 1997; Heber et al., 2000) . Previous studies, however, failed to identify any overt anatomic abnormalities in these double null animals (von Koch et al., 1997; Heber et al., 2000) .
The expression profile and studies of the Drosophila APP homolog Appl support a potential activity of APP in synaptic modulation (Torroja et al., 1999) . We thus sought to investigate the role of the APP family of proteins in mammalian synapses using the NMJ as a model system. Structural and functional analyses of the developing NMJ reveal a critical role of the APP family of proteins in the formation or differentiation of neuromuscular synapses. Mice doubly deficient in APP and APLP2 show an impaired synaptic structure and defective synaptic transmission.
Materials and Methods
Antibodies and reagents. Antibody against SV2 was obtained from Developmental Studies Hybridoma Bank (Iowa City, IA); antisynaptophysin (Syn), anti-neurofilament (NF), and anti-S100 antibodies were purchased from Synaptic Systems, Chemicon (Temecula, CA), and Swant, respectively. ␣-Bungarotoxin (␣BTX) was purchased from Molecular Probes (Eugene, OR). The anti-APP C-terminal antibody was described previously (Xia et al., 2002) .
Immunohistochemistry. Sternomastoid and diaphragm muscles were dissected from embryos or newborn pups and fixed in 4% paraformaldehyde. The diaphragm muscle was stained whole mount, and the sternomastoid muscle was sectioned at 20 M thickness. Tissues were blocked with 5% goat serum, incubated with primary antibodies at 4°C overnight, washed in PBS, incubated with 1:1000 Alexa Fluor-488-or Alexa Fluor-594-conjugated secondary antibody (Molecular Probes) for 1 h at room temperature, washed in PBS, and mounted in glycerol/PBS. Confocal images were obtained with an Axioskop 2 microscope (Zeiss, Oberkochen, Germany). The quantitation of percentage of coverage was done using the ImageJ program from the National Institutes of Health.
Electron microscopy. Mice were deeply anesthetized with avertin (0.2 ml/10 g body weight, i.p., of a 1.25% solution), perfused with PBS, and fixed in 2.5% glutaraldehyde and 2% paraformaldehyde. Sternomastoid muscles containing nerve terminals were dissected, treated, and serial sectioned. Sections were photographed at 5000 -10,000ϫ magnification with a Phillips (Eindhoven, The Netherlands) CM 120 electron microscope, and the developed negatives were scanned at 600 dpi on an MI-CROTEK NuScan 1200. Twenty randomly selected profiles of various sizes from each mouse and two mice per genotype were selected for quantification.
Electrophysiology. Postnatal day 0 (P0) sternomastoid muscles were studied in a chamber perfused with oxygenated saline containing (in mM) 145 NaCl, 2 KCl, 1 MgSO 4 , 2 CaCl 2 , 10 NaHEPES, and 10 glucose, pH 7.1, at 19 -22°C. Nerves were stimulated by a suction electrode via an isolation unit (WPI Instruments, Waltham, MA) triggered by pClamp software at low frequency (Ͻ0.5/s). Signals from -conotoxin GIIIblocked muscle fibers impaled with KCl-filled micropipettes (15-45 M⍀) were amplified (Axoclamp-2A; Axon Instruments, Union City, CA) and digitized at 30 s (for evoked release) or 100 -500 s (for spontaneous release). Fibers with membrane potential below Ϫ50 mV, stable end plate potential (EPP) morphology with rise time Յ1 ms, and low stimulation thresholds for evoking EPPs (typically Յ1 mA) were analyzed. , herein referred to as dKO or APP/APLP2 null). At birth, neither the single nor double knock-outs were distinguishable from the WT controls. This stage was chosen for most of the analyses.
Results

Impaired
The mammalian NMJ is a highly specialized synaptic structure in which the presynaptic terminals of motor neuron axons are closely apposed to postsynaptic acetylcholine receptors (AChRs) of the muscle fiber (Sanes and Lichtman, 1999) . To examine NMJ structures, sternomastoid muscle sections of P0 mice were stained with an antibody against Syn, a synaptic vesicle protein that labels presynaptic nerve terminals. For postsynaptic end plate, Texas Red-conjugated ␣-BTX was used to label AChRs. In the WT NMJ, AChR clusters were formed at the end plate band of the muscle fiber and were closely apposed by Syn-containing synaptic vesicles ( To determine whether the sparse presynaptic marker staining in the absence of APP/APLP2 is specific for Syn, muscle sections were stained with antibody to another synaptic vesicle protein, SV2. Similar to Syn staining, the SV2 immunoreactivity was comparable among wild type, APP Ϫ/Ϫ (data not shown), and APLP2 Ϫ/Ϫ ( Fig. 1 Ba), whereas the APP/APLP2 dKO NMJ showed sparse SV2 staining at the end plate and abnormal apposition with postsynaptic AChRs (Fig. 1 Bd-f ). Staining of Ͼ50 APP/APLP2 null end plates documented that this phenotype can be invariably identified. Quantitative analysis established that the percentages of coverage of ␣-BTX-positive end plate by SV2 immunoreactivity in the APLP2 null and APP/APLP2 dKO NMJs were ϳ60 and 25%, respectively (Fig. 1C) . This reduction at the end plate is not attributable to reduced protein expression because Western blot analysis showed comparable levels of SV2 in the control (APLP2 Ϫ/Ϫ ) and dKO samples (Fig. 1 D) . Similar presynaptic abnormalities were observed with other synaptic marker proteins, including synapsin and synaptotagmin (data not shown). Double labeling using antibodies against SV2 and Syn found that they were colocalized in all four genotypes (data not shown). These observations suggest that the APP family of proteins plays a general role in regulating synaptic vesicles at motor neuron terminals.
In addition to the sparse staining at the end plate, the immunoreactivity of the synaptic vesicle proteins in the APP/APLP2 null NMJ often extended beyond the end plate ( Fig. 1 B, arrowheads). To substantiate this finding, we performed triple labeling of Syn, NF, and ␣-BTX of P0 sternomastoid muscle sections (Fig.  2) . In WT (Fig. 2a-d) , APP Ϫ/Ϫ (Fig. 2e-h) , and APLP2 Ϫ/Ϫ (Fig.  2i-l ) preparations, the presynaptic distributions were highly compatible with postsynaptic AChR clusters (Fig. 2 , compare a with c, e with g, and i with k), and the NF-positive nerve branches mostly terminated at the end plates (Fig. 2d,h,l ) . In APP/APLP2 dKO samples (Fig. 2m-p) , two abnormalities were readily detectable: (1) the presynaptic distribution was dramatically different from the other genotypes (Fig. 2, compare m with a, e, i) , and there was impaired patterning of the presynaptic protein with postsynaptic end plates (Fig. 2, compare m, o) ; and (2) significant NF-positive nerve terminals, positive for Syn, escaped from the NMJs and extended beyond end plates (Fig. 2m-p, arrowheads) . Thus, aberrant presynaptic structure and nerve terminal sprouting are two phenotypes present in APP/APLP2 null NMJs.
Because APLP2 Ϫ/Ϫ animals were indistinguishable from the WT mice as judged by immunostaining methods (Figs. 1, 2) , littermate APLP2 null mice were used as controls in future studies.
Reduced synaptic vesicle density in APP/APLP2 null NMJ Having identified a presynaptic defect in the APP/APLP2 dKO NMJ, we performed serial electron microscopy (EM) analysis of the P0 sternomastoid muscles. Consistent with the sparse staining patterns of presynaptic marker proteins, we observed a dramatic reduction in synaptic vesicle number in presynaptic terminals of APP/ APLP2 null mice (Fig. 3 A, B) . Quantitatively, the vesicle density (number of synaptic vesicles per square micrometer of profile area) was reduced by 2.1-fold (APLP2 null, 80.15 Ϯ 2.02; APP/APLP2 null, 37.83 Ϯ 2.23) (Fig. 3D) . Although active zones were formed in the APP/APLP2 null NMJ (Fig. 3C) , a reduction in the number of active zones per profile length was observed (APLP2 Ϫ/Ϫ , 0.95 Ϯ 0.05; dKO, 0.497 Ϯ 0.035) (Fig. 3E) . The number of docked vesicles (defined as the vesicles within 150 nm from the plasma membrane in an active zone) was similar between the APLP2 null and the APP/ APLP2 null NMJ (Fig. 3F ) . This finding establishes an important role of APP/ APLP2 in the control of synaptic vesicles at the presynaptic terminals.
Excessive nerve terminal sprouting in the absence of APP/APLP2
The mammalian NMJ undergoes dynamic changes during development. At embryonic day 14.5 (E14.5), the nerve branches of motor axon bundles initiate contact with muscle fibers. However, specialized interactions between the two cell types have not been established at this developmental time, and the AChR-rich end plates exist in a nerve-independent manner (Lin et al., 2001) . In contrast, at E16.5 and onward, the nerve terminals play an active role in stimulating and clustering AChRs at the sites of nerve-muscle contact, leading to close apposition of postsynaptic AChR clusters to presynaptic terminals (Sanes and Lichtman, 1999) .
The above analysis of sternomastoid muscle sections revealed a terminal sprouting defect in the APP/APLP2 null NMJ (Figs. 1,  2) . To characterize this phenotype on a whole-mount level and to determine the onset of the terminal sprouting, we examined the intramuscular nerves of the diaphragm at various developmental stages by immunostaining with an anti-NF antibody (Fig. 4) . At all stages examined, the main nerve structures were comparable between the APLP2 Ϫ/Ϫ control and APP/APLP2 dKO mutant. However, excessive branch sprouting can be seen in APP/APLP2 null samples at P0 (Fig. 4, compare a, b) , E18.5 (data not shown), and E16.5 (Fig. 4, compare c, d ), stages when neuromuscular synapses have been established. Interestingly, the branch pattern of the nerve was similar in APLP2 null and dKO at E14.5 (Fig.  4e,f ) , when nerve-muscle contacts were initiated but not specialized (Lin et al., 2001 ). Similar to results obtained from sternomastoid muscles, comparison of APLP2 Ϫ/Ϫ , APP Ϫ/Ϫ , and WT animals of the diaphragm by NF staining at all developmental stages revealed indistinguishable patterns (data not shown). We reasoned that, if sprouting were the primary phenotype, it should be independent of synapse specialization (i.e., such a defect is expected to present at all developmental stages). The fact that terminal sprouting only becomes evident after the onset of synapse specialization supports the idea that abnormal synapse formation or maturation might be the underlying trigger for the terminal sprouting phenotype. However, it is also plausible that the two phenotypes arise from independent mechanisms with similar timing.
Excessive nerve terminal sprouting led to widening of the end plate band in the APP/APLP2 dKO NMJ, as revealed by costaining of NF with ␣-BTX (Fig. 5 A, B, quantified) , and diffused presynaptic distribution, shown by Syn immunoreactivity (Fig. 5C ). However, synapse numbers quantified by the total number of AChR-positive end plates within 5.0 ϫ 105 m 2 muscle area was not significantly different (218 Ϯ 17 and 245 Ϯ 21 for APLP2 null and APP/APLP2 dKO, respectively; average Ϯ SD of three animals per genotype; p ϭ 0.16; t test). A diffused synaptic staining pattern was in agreement with results obtained from sternomastoid muscles (Fig. 2) , indicating that a significant amount of synaptic vesicles extended beyond the synapses to sprouted nerve branches. The abnormal patterning of synapses was further confirmed by acetylcholinesterase histochemistry (Fig. 5D) , which serves as a reliable marker for synaptic sites (Brandon et al., 2003) .
The neuromuscular synapses form as a result of complex interactions between nerve terminals, Schwann cells, and muscle fibers. Labeling of Schwann cells with anti-S100 antibody revealed a similar pattern as NF in both the control and the dKO mutant, suggesting that Schwann cells were distributed in close proximity with nerve terminals (data not shown). Muscle histology was comparable in the APP/APLP2 null and the control (data not shown). These data combined support a primary effect of APP/APLP2 at the nerve terminals. 
Functional analysis of APP/APLP2 null NMJ
To determine whether the structural abnormalities described above lead to functional impairment in synaptic transmission, intracellular recordings of P0 sternomastoid muscle fibers were performed. Consistent with the immunostaining results, no appreciable differences between WT and APLP2 Ϫ/Ϫ samples could be identified (data not shown). However, compared with littermate APLP2 null animals, dramatically reduced miniature EPP (MEPP) frequency was observed in APP/APLP2 null mice (Fig.  6 Aa). Similar differences in MEPP frequency were seen in preparations blocked with -conotoxin GIII (data not shown). Resting membrane potentials (data not shown) and MEPP amplitudes (Fig. 6 Ab) of sampled fibers were similar. The threshold current applied to the nerve to evoke a muscle response and the latency from the shock artifact to the initiation of the EPP were similar among all groups (data not shown). Significantly, the proportion of fibers in which an EPP could not be evoked by supramaximal nerve stimulation was much greater in APP/ APLP2 null mice than in control littermates (Fig. 6 B) , and these fibers also lacked MEPPs. These findings suggest a defect of presynaptic terminal function at NMJs of APP/APLP2 null mice, with a substantial proportion of nonfunctioning synapses.
Discussion
We report here an essential role of the APP family of proteins in developing neuromuscular synapses. We show that APP/APLP null NMJs exhibit abnormal apposition of presynaptic proteins with postsynaptic AChR clusters and a dramatically reduced number of synaptic vesicles at presynaptic terminals. Electrophysiological recordings establish a functional deficit of the mutant in synaptic transmission. In addition to aberrant synapses, excessive nerve terminal sprouting is another feature present in the APP/APLP2 dKO NMJ. These phenotypes are, to a large degree, overlapped with mice deficient in choline acetyltransferase (ChAT), the biosynthetic enzyme for acetylcholine. Analysis of the ChAT knock-out animals documents that lack of synaptic transmission attributable to the absence of neurotransmitter results in nerve terminal sprouting and aberrant synaptic patterning (Misgeld et al., 2002; Brandon et al., 2003) . It is hypothesized that the release of acetylcholine from the nerve terminals acts on muscle to arrest nerve growth (Brandon et al., 2003) . Thus, it is reasonable to speculate that defective synapse formation in the absence of APP/APLP2 leads to reduced synaptic transmission, followed by nerve terminal sprouting. However, current studies do not prove a cause-effect relationship. It is also possible that impaired synaptic transmission is the primary phenotype for the synapse formation/maturation and nerve terminal sprouting defects seen in APP/ APLP2 null NMJs.
Intracellular recording of P0 sternomastoid muscle revealed a dramatic reduction of MEPP frequency and a higher percentage of fibers lacking EPP in the APP/APLP2 null NMJ. These data implicate a presynaptic defect and are consistent with our ultrastructural analysis documenting a decreased number of synaptic vesicles and active zones. Similar MEPP amplitudes in APP/APLP2 null and control littermates suggest that a significant postsynaptic deficit in APP/APLP2 null NMJs is unlikely, although subtle differences cannot be ruled out. Intriguingly, among fibers that showed evoked responses, the EPP amplitude did not differ significantly between the dKO mutant (23 Ϯ 10 mV; n ϭ 17 fibers) and the control (27 Ϯ 8 mV; n ϭ 19 fibers) ( p ϭ 0.25), indicating normal quantal content in this subpopulation of fibers. By combining with our EM data, we provide two possible explanations for this phenomenon: (1) a reduction in the number of active zones in the APP/APLP2 null NMJ may lead to a compensatory increase in the release probability, resulting in apparent normal quantal content (Urbano et al., 2003) ; and (2) the normal number of docked vesicles in APP/APLP2 null active zones may be sufficient to produce normal EPP amplitude after initial stimulation. Additional analysis, such as paired-pulse and repetitive stimulation, is required to allow a definitive answer to this question.
The NMJ phenotypes in APP/APLP2 mutants are somewhat distinct from Appl null Drosophila, because the latter exhibits a subtle reduction of synaptic bouton numbers without structural alterations (Torroja et al., 1999) . Whether the mutant fly is functionally impaired is not clear. The relative mild phenotype could be attributed by compensatory mechanisms through a yet unidentified family member. Indeed, neither APP nor APLP2 single knock-out mice show overt NMJ defect. In this regard, it is also interesting to note that both Appl and APP null mutants are viable, whereas mice deficient in APP and APLP2 are early postnatal lethal.
APP has been reported to function as a receptor for kinesinmediated axonal transport (Kamal et al., 2000 (Kamal et al., , 2001 Gunawardena and Goldstein, 2001 ). Loss of Appl in Drosophila leads to vesicle "clogging" along the axons. Thus, defective vesicle trafficking can be considered as a candidate mechanism for the reduced synaptic vesicles at the nerve terminals of the APP/APLP2 null NMJ. The early postnatal lethal phenotype of the APP/ APLP2 null mice prevents direct measurement of the axonal transport rate using the sciatic ligation method as reported pre- viously (Kamal et al., 2001) . Nevertheless, examination of individual motoneuron axons within a main phrenic nerve bundle by NF staining and high-power confocal microscopic imaging revealed uniform and indistinguishable patterns of axonal structures in the control and APP/APLP2 dKO samples across the entire region surveyed (total, 400 m in length; data not shown), indicating that there was no axonal swelling caused by impaired trafficking. Our findings that total levels of Syn immunoreactivity at the end plate bands were comparable between the control and APP/APLP2 null (Fig. 5C) , and that synaptic vesicle proteins were not only transported to the nerve terminals but were also expressed in sprouted nerves beyond end plates in the mutant (Fig.  2) , argue against a major function of APP/APLP2 in synaptic vesicle trafficking during NMJ development. Other defects, including vesicle biogenesis, vesicle release, or endocytosis, are possible contributing factors for the presynaptic phenotype in the APP/APLP2 null NMJ.
APP as well as its family members APLP1 and APLP2 undergoes extracellular and presenilin-dependent intramembrane cleavages to generate secreted APP (sAPP), A␤ peptides, and APP intracellular domain (AICD). sAPP has been suggested to exhibit neurotrophic, synaptogenic, and growth-promoting properties (Jin et al., 1994; Ohsawa et al., 1999; Rossjohn et al., 1999) , and AICD has been reported to function in transcriptional regulation (Cao and Sudhof, 2001) . A potential role of presenilin-dependent APP processing and signaling cannot be tested directly because of the early lethal phenotype of PS1/PS2 double null embryos (Donoviel et al., 1999; Herreman et al., 1999) and a large number of potential PS processing substrates reported (for review, see De Strooper, 2003) . Preliminary assessment of the PS1 null NMJ in late embryogenesis did not identify any overt abnormalities (data not shown). Finally, it remains a possibility that the large secreted form of APP is the major functional moiety responsible for the effects seen in this study, because its level coincides with synaptogenesis (Moya et al., 1994) .
In summary, we present here an indispensable role of the APP family of proteins in the formation, maturation, and function of neuromuscular synapses. Although the exact mechanism is under intensive study, this is the first report documenting an in vivo physiological function of the APP family of proteins in the mammalian system. In addition to the questions raised for NMJ development, the presynaptic effects have direct implications for a similar role of APP/APLP2 in CNS synapse as well as synaptic dysfunction contributing to AD dementia. Ϫ/Ϫ control; bottom trace, EPP from a littermate mutant (dKO), at 10 times the threshold required to evoke responses in adjacent muscle fibers.
